Can Excess U.S. Production Capacity be a Key to Essential Medicines Production?
An AAM blog posted this morning (here), titled The Quickest Route to U.S. Essential Medicines Production: Existing and Idle Production Sites, seems to think that the answer to this post’s titular question is Yes, and it at least provides another option for consideration. The AAM post cites a report (here) by Professor Anthony Sardella from […]
